查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1666190

全球医疗旅游市场 - 2025 年至 2033 年

Global Medical Tourism Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 156 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024 年全球医疗旅游市场规模达到 470.9 亿美元，预计到 2033 年将达到 2,303.5 亿美元，2025-2033 年预测期内的复合年增长率为 19.4%。

医疗旅游是指前往另一个国家或地区寻求医疗，通常是因为该国提供比旅行者本国更实惠、更高品质或更专业的护理。它涵盖各种医疗保健服务，包括选择性手术、牙科、整容手术、生育治疗以及更复杂的手术或医疗干预。总体而言，医疗旅游是一个不断发展的行业，其动力源于人们对负担得起的高品质医疗服务的需求，以及将治疗与旅行相结合的便利性。然而，患者在进行医疗旅游之前必须对目的地国家、医疗保健提供者和任何相关风险进行彻底的研究。

过去几十年来，医疗旅游市场经历了快速增长，推动因素包括已开发国家医疗成本的上涨、医疗技术的进步、全球化以及旅游成本的下降。例如，根据医疗旅游协会的数据，每年约有 1400 万人出国接受医疗，来自英国和美国等发达国家的患者通常会前往欠发达国家获得医疗服务，而且费用比在国内低得多。

市场动态：

驱动因素与约束因素

人们对医疗程序低成本的认识不断提高

人们对医疗程序低成本的认识不断提高，极大地推动了医疗旅游市场的成长，预计将在预测期内推动市场的发展。医疗旅游的主要动机是患者可以透过到其他国家接受治疗并获得更好的治疗效果来节省大量费用。这进一步为患者提供了更好、更实惠的治疗。

例如，2022 年 8 月，印度卫生部启动了一项新倡议，即“印度治愈，印度治愈”，这是总理宣布的一个新门户网站。新入口网站旨在推动医疗旅游的发展。该入口网站是在「印度医疗数位使命」计划下开发的，将拥有医疗保健专业人员和医院服务资源，以帮助海外患者以可负担的费用在印度寻求医疗帮助。

人们对医疗程序低成本的认识不断提高，加速了医疗旅游市场的需求，从而增加了接受各种程序的医疗游客的数量。例如，根据 Lively, Inc. 的数据，在印度，冠状动脉绕道手术平均花费约为 10,000 美元，在墨西哥，冠状动脉绕道手术平均花费约为 40,000 美元（不包括往返目的地的旅费，也不包括出院后在墨西哥的恢復费用），而在美国，该手术的平均费用为 123,000 美元。

据DentaVacation称，匈牙利的牙医费用比英国和其他西欧国家低 40-70%。在匈牙利，四颗牙齿植入等手术每牙弓费用为 5,200 美元，而在英国，同样的手术费用为 15,000 美元。在匈牙利，我们只需花费 405 美元就能买到瓷贴面，而在英国，则需要花费高达 1,100 美元。

此外，根据全球医疗保健认证，墨西哥在医疗旅游业排名第三，得分为70.05。墨西哥的医疗旅游业正在不断发展，拥有高品质的医疗设施和实惠的医疗费用。整形外科和癌症治疗领域的领导者。韩国卫生福利部 (MOHW，部长 Cho Kyoo Hong) 宣布，2023 年有 606,000 名外国患者访问韩国，比 2022 年的 248,000 名增长了 2.4 倍（144.2%）。

医疗旅行是一个耗时的过程，并且会产生一些额外费用

儘管医疗旅游业发展迅速，但也面临着一些可能阻碍其扩张的挑战，其中主要的问题之一是医疗旅游是一个耗时的过程，并且会产生额外的费用。这些因素可能会阻止潜在患者选择出国治疗。出国就医不只是预订航班那么简单。它通常需要一个漫长的规划过程，包括获得签证、寻找医疗服务提供者、安排咨询和确保适当的后续护理。对于时间有限或需要紧急护理的患者来说，这可能是一个重大障碍。

儘管在国外接受医疗程序本身可能更便宜，但可能会产生额外的旅游相关费用。这些费用包括机票、住宿、交通以及目的地国家治疗后护理或延长逗留的额外费用。对于部分患者来说，这可能会降低医疗旅游的整体成本效益。例如，墨西哥整容手术的医疗旅游套餐手术费用可能在 3,000 至 5,000 美元之间，但总费用（包括航班、住宿和术后护理）很容易达到 6,000 至 8,000 美元，因此比预期的要低。

目录

第一章：市场介绍和范围

  • 报告目标
  • 报告范围和定义
  • 报告范围

第 2 章：高阶主管见解与关键要点

  • 市场亮点和战略要点
  • 主要趋势和未来预测
  • 按类型分类的程式码片段
  • 治疗片段
  • 按地区分类的片段

第 3 章：动态

  • 影响因素
    • 驱动程式
      • 提高对医疗程序低成本的认识
    • 限制
      • 医疗旅行是一个耗时的过程，并且会产生一些额外费用
    • 机会
    • 影响分析

第四章：战略洞察与产业展望

  • 市场领导者和先驱者
    • 新兴先锋和杰出参与者
    • 拥有最大销售品牌的成熟领导者
    • 拥有成熟产品的市场领导者
  • CXO 观点
  • 最新进展与突破
  • 监管和报销情况
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 波特五力分析
  • 供应链分析
  • 专利分析
  • SWOT 分析
  • 未满足的需求和差距
  • 市场进入和扩张的推荐策略
  • 情境分析：最佳情况、基本情况和最坏情况预测
  • 定价分析和价格动态
  • 关键意见领袖
  • 医疗旅游的未来

第 5 章：医疗旅游市场（按类型）

  • 国际医疗旅游
  • 国内医疗旅游

第 6 章：医疗旅游市场（依治疗方式划分）

  • 医疗
    • 牙科治疗
    • 器官移植
    • 心臟手术
    • 骨科手术
    • 癌症手术
    • 生育治疗
    • 整形外科
    • 其他的
  • 健康和恢復活力
  • 透过传统医学体系治愈

第七章：医疗旅游市场，依区域市场分析与成长机会

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲

第 8 章：竞争格局与市场定位

  • 竞争概况和主要市场参与者
  • 市占率分析与定位矩阵
  • 策略伙伴关係、併购
  • 产品组合和创新的关键发展
  • 公司基准化分析

第九章：公司简介

  • Raffles Medical Group
    • 公司概况
    • 产品组合和描述
    • 财务概览
    • 主要进展
    • SWOT 分析
  • Medobal
  • Bookimed
  • RealSelf, Inc.
  • KPJ Healthcare Berhad
  • Japan Dream Tour Co., Ltd.
  • JTB Corp.
  • SilaMed eK
  • Medibliss Tours Limited
  • American Medical Care

第 10 章：假设与研究方法

  • 资料收集方法
  • 数据三角测量
  • 预测技术
  • 数据验证和确认

第 11 章：附录

简介目录
Product Code: HCIT1091

The global medical tourism market reached US$ 47.09 billion in 2024 and is expected to reach US$ 230.35 billion by 2033, growing at a CAGR of 19.4% during the forecast period 2025-2033.

Medical tourism refers to traveling to another country or region to seek medical treatment, often because it offers more affordable, higher-quality or specialized care than what is available in the traveler's home country. It encompasses various healthcare services, including elective procedures, dental, cosmetic surgeries, fertility treatments and more complex surgeries or medical interventions. Overall, medical tourism is a growing industry fueled by the desire for affordable, high-quality healthcare and the convenience of combining treatment with travel. However, patients must conduct thorough research regarding destination countries, healthcare providers and any associated risks before pursuing medical tourism.

The medical tourism market has seen rapid growth over the past few decades, driven by a combination of factors including rising healthcare costs in developed countries, advancements in medical technology, globalization, and the increasing affordability of travel. For instance, around 14 million people travel abroad each year to receive medical treatment, according to the Medical Tourism Association, with patients from developed nations such as the UK and the US typically traveling to less-developed countries to access health services at a significantly lower cost than they could at home.

Market Dynamics: Drivers & Restraints

Rising awareness about the low cost of medical procedures

The rising awareness about the low cost of medical procedures is significantly driving the growth of the medical tourism market and is expected to drive the market over the forecast period. The primary motivation for medical tourism is the substantial cost savings that patients can achieve by seeking medical treatment in other countries with better patient outcomes. This further initiated more for better and more affordable treatments for the patients.

For instance, in August 2022, the Union Health Ministry launched a new initiative, heal in India and heal by India, a new portal announced by the prime minister. The new portal aims to give impetus to medical tourism. Developed under the Ayushman Bharat Digital Mission, the portal will have a repository of healthcare professionals and hospital services to help overseas patients seeking medical help in India at an affordable cost.

Rising awareness about the low cost of medical procedures accelerates the medical tourism market demand, which increases the number of medical tourists for various procedures. For instance, according to Lively, Inc., a coronary bypass averages around $10,000 in India and $40,000 in Mexico (not including travel to and from the destination, or in-country recovery after release from the hospital) and $123,000 the average procedure costs in America.

According to DentaVacation, in Hungary, dentist prices are 40-70% less than in the UK and other Western European countries. Procedures like all 4 dental implants in Hungary cost $5,200 per arch, while the same costs $15,000 in the UK. We can get porcelain veneers in Hungary at $405, whereas in the UK, they'll cost a whopping $1,100.

Additionally, according to the Global Healthcare Accreditation, Mexico ranked third in the medical tourism industry, with a score of 70.05. Mexico has a growing medical tourism industry, with high-quality medical facilities and affordable medical costs. A leader in cosmetic surgery and cancer treatment. The Ministry of Health and Welfare (MOHW, Minister Cho KyooHong) announced that 606,000 foreign patients visited Korea in 2023, achieving a 2.4 times growth (144.2%) from 248,000 in 2022. These low cost procedures awareness boosts the market demand.

Medical traveling is a time-consuming process and is associated with some additional costs

Although medical tourism has been growing rapidly, it does come with certain challenges that can hamper its expansion, one of the primary concerns being that medical traveling is a time-consuming process and can incur additional costs. These factors can deter potential patients from opting for treatment abroad. Traveling abroad for medical treatment involves more than just booking a flight. It typically requires a lengthy planning process that includes obtaining visas, researching medical providers, scheduling consultations and ensuring appropriate aftercare. This can be a significant barrier for patients with limited time or those needing urgent care.

While the medical procedure itself may be much more affordable abroad, additional travel-related costs can accumulate. These include airfares, accommodation, transport and often extra costs for post-treatment care or extended stays in the destination country. This can reduce the overall cost-effectiveness of medical tourism for some patients. For instance, a medical tourism package for cosmetic surgery in Mexico may cost between $3,000 to $5,000 for the surgery, but the total cost (including flights, accommodation, and post-operative care) can easily reach $6,000 to $8,000, making it less affordable than anticipated.

Segment Analysis

The global medical tourism market is segmented based on type, treatment and region.

Treatment:

The medical treatment segment is expected to dominate the medical tourism market share

The medical treatment segment is the dominant segment in the medical tourism market, contributing significantly to its growth. This segment includes a wide range of medical services such as surgeries, dental procedures, fertility treatments and cosmetic surgery, all of which are key drivers of medical tourism.

For instance, according to the Global Healthcare Accreditation, the data (pre-pandemic levels), the below countries have statistics and data available for medical tourism. Some countries showcase inbound and other outbound data with the average number of patients and primary types of medical procedures sought as follows:

Surgical treatments, both elective and non-elective, make up a substantial part of the medical tourism market. High-demand surgeries like orthopedic surgeries, cardiac surgeries, cosmetic surgeries and spinal surgeries drive many patients to seek affordable and high-quality care abroad. Cosmetic surgery is one of the fastest-growing sectors within medical tourism. Procedures such as breast augmentation, liposuction, facelifts, bariatric surgery and dental implants draw a large number of international patients seeking quality and affordability abroad.

Geographical Analysis

Asia-Pacific is expected to hold a significant position in the medical tourism market share

The Asia-Pacific region is undeniably the dominant region in the medical tourism market, attracting millions of international patients each year due to its high-quality healthcare services, cost-effectiveness and well-established medical infrastructure. The dominance of the APAC region in medical tourism is driven by several factors, including the affordability of treatments, the availability of world-class healthcare facilities and the expertise of medical professionals.

For instance, India is experiencing a surge in medical tourism, with a significant increase in medical tourists from Myanmar, Bangladesh and Nepal. Despite being impacted by the coronavirus pandemic, India is becoming a popular destination for 'medical value travel', and its potential in this sector is expected to grow further. In 2024, India is expected to cater to around 7.3 million medical tourists, up from an estimated 6.1 million in 2023, according to credit rating agency Crisil.

Additionally, Thailand has become a world-renowned leader in medical tourism, attracting visitors worldwide with strong support from Thailand's Medical Tourism Association and the Thai government. According to the MedPark Hospital, in 2023, Thailand's medical tourism industry is expected to be worth $6 billion, with an estimated 3 million medical tourists receiving exceptional medical treatment and rehabilitation programs for a variety of medical fields.

The APAC region is home to many internationally accredited hospitals and healthcare facilities that provide high standards of medical care. Countries like Singapore, India, Thailand and South Korea have developed reputations for excellent healthcare infrastructure, attracting patients from across the globe. For instance, India is home to top-tier hospitals like Apollo Hospitals, Fortis Healthcare and Max Healthcare, which provide high-quality care for a wide range of medical procedures. Many of these hospitals have been accredited by global standards such as JCI, ensuring international patients receive the best care.

Competitive Landscape

The major global players in the medical tourism market include Raffles Medical Group, Medobal, Bookimed, RealSelf, Inc., KPJ Healthcare Berhad, Japan Dream Tour Co., Ltd., JTB Corp., SilaMed e.K., Medibliss Tours Limited, American Medical Care and among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global medical tourism market report delivers a detailed analysis with 54 key tables, more than 41 visually impactful figures and 156 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Type
  • 2.4. Snippet by Treatment
  • 2.5. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising Awareness About the Low Cost of Medical Procedures
    • 3.1.2. Restraints
      • 3.1.2.1. Medical Traveling is a Time-Consuming Process and is Associated with Some Additional Costs
    • 3.1.3. Opportunity
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. CXO Perspectives
  • 4.3. Latest Developments and Breakthroughs
  • 4.4. Regulatory and Reimbursement Landscape
    • 4.4.1. North America
    • 4.4.2. Europe
    • 4.4.3. Asia Pacific
    • 4.4.4. Latin America
    • 4.4.5. Middle East & Africa
  • 4.5. Porter's Five Force Analysis
  • 4.6. Supply Chain Analysis
  • 4.7. Patent Analysis
  • 4.8. SWOT Analysis
  • 4.9. Unmet Needs and Gaps
  • 4.10. Recommended Strategies for Market Entry and Expansion
  • 4.11. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.12. Pricing Analysis and Price Dynamics
  • 4.13. Key Opinion Leaders
  • 4.14. Future of Medical Tourism

5. Medical Tourism Market, By Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 5.1.2. Market Attractiveness Index, By Type
  • 5.2. International Medical Tourism*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Domestic Medical Tourism

6. Medical Tourism Market, By Treatment

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment
    • 6.1.2. Market Attractiveness Index, By Treatment
  • 6.2. Medical Treatment*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 6.2.3. Dental Treatment
    • 6.2.4. Organ Transplantation
    • 6.2.5. Cardiac Surgery
    • 6.2.6. Orthopedic Surgery
    • 6.2.7. Cancer Surgery
    • 6.2.8. Fertility Treatment
    • 6.2.9. Cosmetic Surgery
    • 6.2.10. Others
  • 6.3. Wellness and Rejuvenation
  • 6.4. Cures Through Traditional Systems of Medicines

7. Medical Tourism Market, By Regional Market Analysis and Growth Opportunities

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 7.1.2. Market Attractiveness Index, By Region
  • 7.2. North America
    • 7.2.1. Introduction
    • 7.2.2. Key Region-Specific Dynamics
    • 7.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment
    • 7.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 7.2.5.1. U.S.
      • 7.2.5.2. Canada
      • 7.2.5.3. Mexico
  • 7.3. Europe
    • 7.3.1. Introduction
    • 7.3.2. Key Region-Specific Dynamics
    • 7.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment
    • 7.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 7.3.5.1. Germany
      • 7.3.5.2. U.K.
      • 7.3.5.3. France
      • 7.3.5.4. Spain
      • 7.3.5.5. Italy
      • 7.3.5.6. Rest of Europe
  • 7.4. South America
    • 7.4.1. Introduction
    • 7.4.2. Key Region-Specific Dynamics
    • 7.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment
    • 7.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 7.4.5.1. Brazil
      • 7.4.5.2. Argentina
      • 7.4.5.3. Rest of South America
  • 7.5. Asia-Pacific
    • 7.5.1. Introduction
    • 7.5.2. Key Region-Specific Dynamics
    • 7.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment
    • 7.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 7.5.5.1. China
      • 7.5.5.2. India
      • 7.5.5.3. Japan
      • 7.5.5.4. South Korea
      • 7.5.5.5. Rest of Asia-Pacific
  • 7.6. Middle East and Africa
    • 7.6.1. Introduction
    • 7.6.2. Key Region-Specific Dynamics
    • 7.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment

8. Competitive Landscape and Market Positioning

  • 8.1. Competitive Overview and Key Market Players
  • 8.2. Market Share Analysis and Positioning Matrix
  • 8.3. Strategic Partnerships, Mergers & Acquisitions
  • 8.4. Key Developments in Product Portfolios and Innovations
  • 8.5. Company Benchmarking

9. Company Profiles

  • 9.1. Raffles Medical Group*
    • 9.1.1. Company Overview
    • 9.1.2. Product Portfolio and Description
    • 9.1.3. Financial Overview
    • 9.1.4. Key Developments
    • 9.1.5. SWOT Analysis
  • 9.2. Medobal
  • 9.3. Bookimed
  • 9.4. RealSelf, Inc.
  • 9.5. KPJ Healthcare Berhad
  • 9.6. Japan Dream Tour Co., Ltd.
  • 9.7. JTB Corp.
  • 9.8. SilaMed e.K.
  • 9.9. Medibliss Tours Limited
  • 9.10. American Medical Care

LIST NOT EXHAUSTIVE

10. Assumption and Research Methodology

  • 10.1. Data Collection Methods
  • 10.2. Data Triangulation
  • 10.3. Forecasting Techniques
  • 10.4. Data Verification and Validation

11. Appendix

  • 11.1. About Us and Services
  • 11.2. Contact Us